Evidence map›Paper›PMID 40435493›Full record

ArticleJMIR research protocols2025

Evaluation of Noninvasive Adjuncts for Early Detection of Oral Cancer in Oral Potentially Malignant Disorders and Development of Risk-Based Management Strategies: Protocol for a Prospective Longitudinal Study.

Ruchika Gupta, Apurva Ratnu, Shalini R Gupta, Hariprakash Hadial, Lucky Singh, Prashant Kumar Singh, Shalini Singh

Abstract read
In one paragraph

Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruchika Gupta *ICMR-National Institute of Cancer Prevention and Research, Noida, India.ORCID 0000-0003-0235-063X
Apurva Ratnu *Niramay Charitable Trust, Gandhinagar, India.ORCID 0000-0002-8590-2745
Shalini R GuptaCentre for Dental Education and Research, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0001-7055-4269
Hariprakash HadialNiramay Charitable Trust, Gandhinagar, India.ORCID 0009-0005-2345-4253
Lucky SinghIndian Council of Medical Research, New Delhi, India.ORCID 0000-0003-2590-6135
Prashant Kumar SinghICMR-National Institute of Cancer Prevention and Research, Noida, India.ORCID 0000-0003-1742-5534
Shalini SinghICMR-National Institute of Cancer Prevention and Research, Noida, India.ORCID 0000-0002-8271-1062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral potentially malignant disorders (OPMDs) constitute the most important precursors of oral cancer. Histopathological examination of a biopsy from a clinically suspicious lesion is still the gold standard for the diagnosis of oral cancer. Adjunctive techniques such as autofluorescence, toluidine blue (TB), and others have been evaluated among high-risk individuals such as chronic tobacco chewers or in patients with suspicious lesions. However, evaluation of these noninvasive adjunctive techniques has not been performed in primary health care settings. Since the first point-of-contact of individuals living in rural and semiurban areas are the primary health care workers, evaluation of these noninvasive adjuncts is likely to assist and strengthen the population-wide oral cancer screening in high-burden countries such as India.

objectiveThis prospective longitudinal study aims to evaluate the noninvasive adjuncts in oral cancer screening in the field settings, specifically in detecting foci of oral cancers in various OPMDs.

methodsAfter staff recruitment and training, we shall conduct oral cancer screening camps in the community for the recruitment of individuals with OPMDs after obtaining informed consent. All patients with OPMD shall undergo further screening via autofluorescence and TB staining for detection of lesions suspicious of oral cancer. Sensitivity, specificity, and negative and positive predictive values of these adjunctive techniques (autofluorescence and TB) in the detection of oral cancer shall be calculated using biopsy as the gold standard. In addition, this study will also focus on the validation of the 2022 consensus guidelines on risk-based stratification and appropriate management protocols for the OPMDs at the primary and referral health care centers. Our primary outcome is the diagnostic use of autofluorescence and TB in oral cancer detection among OPMDs as well as the robustness of the risk-based management protocols for these patients.

resultsParticipant recruitment has been initiated at all sites. Staff recruitment and training in the oral visual examination have been conducted. Procurement of the autofluorescence device is in progress. All the study sites have begun conducting oral screening camps.

conclusionsThe results of this study shall provide robust evidence for the diagnostic use of autofluorescence and TB staining in early oral cancer detection among patients with OPMD. The use of these noninvasive adjuncts by primary health care providers can significantly improve oral cancer screening in our country. The validation of risk-based stratification and management of patients with OPMD shall assist in the refinement of the national guidelines for these interventions. This study has been approved by the respective ethics committee of ICMR-National Institute of Cancer Prevention and Research and the collaborating institutes. The findings of this study shall be disseminated through scientific publications in peer-reviewed journals as well as meetings with the concerned stakeholders at the district and state health departments. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/66285.

Indexed as

Early Detection of CancerMouth NeoplasmsPrecancerous ConditionsHumansIndiaLongitudinal StudiesProspective StudiesRisk ManagementTolonium ChlorideTolonium Chlorideautofluorescencemanagementnoninvasive adjunctoral potentially malignant disorderrisk stratificationtoluidine blue

Identifiers

PMID40435493
PMCPMC12159550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.